Veeva Systems (NYSE:VEEV) Unveils New CTMS for Efficient Clinical Trial Management
Veeva Systems (NYSE:VEEV) recently announced the launch of Veeva SiteVault CTMS, aiming to enhance clinical trial management efficiency, which coincides with a notable 10% share price increase over the last quarter. The introduction of products like Veeva CRM Pulse, alongside strong Q4 results showing revenue and net income growth, have likely bolstered investor confidence. Despite market volatility due to anticipated U.S. tariffs and mixed general market performance, Veev's sector-specific...